Maarten C. Jansen
Academic Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maarten C. Jansen.
Annals of Surgical Oncology | 2006
Fredericke H. van Duijnhoven; Maarten C. Jansen; Jan M. C. Junggeburt; Richard van Hillegersberg; Arjen M. Rijken; Frits van Coevorden; Joost Rm van der Sijp; Thomas M. van Gulik; Gerrit D. Slooter; Joost M. Klaase; Hein Putter; Rob A. E. M. Tollenaar
BackgroundThe prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe and effective new treatment modality, but its long-term efficacy may be hindered by renewed local tumor growth at the site of RFA. The objectives of this study were to identify risk factors for local RFA failure and to define exclusion criteria for RFA treatment of colorectal liver metastases.MethodsA total of 199 lesions in 87 patients were ablated with RFA. Factors influencing local failure rates were identified and compared with data from the literature.ResultsThe local failure rate was 47.2%, and the average time to local disease progression was 6.5 months. Factors that significantly correlated with increased failure rates were metachronous occurrence of liver metastases, large mean lesion size, and central tumor location.ConclusionsBecause accurate electrode placement is pivotal in achieving adequate tumor necrosis, RFA should not be performed percutaneously when electrode placement is impaired. We suggest that lesions >5 cm and lesions located near great vessels or adjacent organs should be treated with open RFA, thus allowing vascular inflow occlusion and complete mobilization of the liver. Lesions that are difficult to reach by electrodes should be approached by an open procedure.
Annals of Surgical Oncology | 2007
Stefaan Mulier; Yicheng Ni; Lars Frich; Fernando Burdio; Alban Denys; Jean-François De Wispelaere; Benoit Dupas; Nagy Habib; Michael F. Hoey; Maarten C. Jansen; Marc Lacrosse; Raymond J. Leveillee; Yi Miao; Peter M. J. Mulier; Didier Mutter; Kelvin K. Ng; Roberto Santambrogio; Dirk L. Stippel; Katsuyoshi Tamaki; Thomas M. van Gulik; Guy Marchal; Luc Michel
BackgroundRadiofrequency (RF) ablation is used to obtain local control of unresectable tumors in liver, kidney, prostate, and other organs. Accurate data on expected size and geometry of coagulation zones are essential for physicians to prevent collateral damage and local tumor recurrence. The aim of this study was to develop a standardized terminology to describe the size and geometry of these zones for experimental and clinical RF.MethodsIn a first step, the essential geometric parameters to accurately describe the coagulation zones and the spatial relationship between the coagulation zones and the electrodes were defined. In a second step, standard terms were assigned to each parameter.ResultsThe proposed terms for single-electrode RF ablation include axial diameter, front margin, coagulation center, maximal and minimal radius, maximal and minimal transverse diameter, ellipticity index, and regularity index. In addition a subjective description of the general shape and regularity is recommended.ConclusionsAdoption of the proposed standardized description method may help to fill in the many gaps in our current knowledge of the size and geometry of RF coagulation zones.
Surgery | 2010
Maarten C. Jansen; Richard van Hillegersberg; Ivo G. Schoots; Marcel Levi; Johan F. Beek; Hans Crezee; Thomas M. van Gulik
BACKGROUND Cryoablation (CA), radiofrequency ablation (RFA), and laser induced thermotherapy (LITT) are alternative therapies for patients with unresectable liver tumors. We investigated whether there are different inflammatory and coagulative responses between these techniques. METHODS Livers of 48 rats were subjected to either CA, RFA, LITT, or sham operation (n = 12 in each group). Blood was withdrawn before, and 1, 3, 6, and 24 h after ablation. Liver enzymes as well as inflammatory and coagulation parameters were determined. Whole liver sections from the coagulated liver lobe were stained for quantification of necrosis and morphologic examination. RESULTS Histologic examination showed similar volume of complete destruction of liver parenchyma after CA, RFA, or LITT. Transaminase levels as well as the inflammatory response upon CA, as reflected by white blood cell count and cytokine levels, were significantly higher than following RFA or LITT. The systemic intravascular procoagulative state in rats that underwent CA, as reflected by platelets, and levels of sensitive markers for activation of coagulation and fibrinolyis, was also significantly higher. CONCLUSION CA of liver in rats induces greater inflammatory and coagulative responses than RFA or LITT. The combined activation of inflammation and coagulation may importantly contribute to the higher morbidity after CA.
Annals of Surgical Oncology | 2011
Nikol Snoeren; Joost Huiskens; Arjen M. Rijken; Richard van Hillegersberg; Arian R. van Erkel; Gerrit D. Slooter; Joost M. Klaase; Petrousjka M. van den Tol; Fibo J.W. Ten Kate; Maarten C. Jansen; Thomas M. van Gulik
BackgroundLocal tumor progression (LTP) is a serious complication after local ablation of malignant liver tumors, negatively influencing patient survival. LTP may be the result of incomplete ablation of the treated tumor. In this study, we determined whether viable tumor cells attached to the needle applicator after ablation was associated with LTP and disease-free survival.MethodsIn this prospective study, tissue was collected of 96 consecutive patients who underwent local liver ablations for 130 liver malignancies. Cells and tissue attached to the needle applicators were analyzed for viability using glucose-6-phosphate-dehydrogenase staining and autofluorescence intensity levels of H&E stained sections. Patients were followed-up until disease progression.ResultsViable tumor cells were found on the needle applicators after local ablation in 26.7% of patients. The type of needle applicator used, an open approach, and the omission of track ablation were significantly correlated with viable tumor tissue adherent to the needle applicator. The presence of viable cells was an independent predictor of LTP. The attachment of viable cells to the needle applicators was associated with a shorter time to LTP.ConclusionsViable tumor cells adherent to the needle applicators were found after ablation of 26.7% of patients. An independent risk factor for viable cells adherent to the needle applicators is the omission of track ablation. We recommend using only RFA devices that have track ablation functionality. Adherence of viable tumor cells to the needle applicator after local ablation was an independent risk factor for LTP.
World Journal of Surgical Oncology | 2006
Bram Fioole; Maarten C. Jansen; Frederieke H van Duijnhoven; Richard van Hillegersberg; Thomas M. van Gulik; Inne H.M. Borel Rinkes
BackgroundThe combination of partial liver resection and radiofrequency ablation (RFA) is a novel concept in the treatment of unresectable liver malignancies. The aim of this study is to evaluate the results of this combined strategy in the Netherlands.MethodsThirty-five patients treated with a combination of partial liver resection and RFA were identified from a prospectively registered pooled multicentre database. All patients were operated between June 1999 and November 2003 in 8 medical centres in the Netherlands. Main outcome parameters were morbidity, mortality, local success rate, and survival.ResultsThirty-seven operations were performed in 35 patients. The group consisted of 20 male and 15 female patients with a median age of 59 years (range 41–76). Seventy-six lesions were resected and RFA was performed to ablate 82 unresectable liver tumours. Twelve patients developed a total of 24 complications, resulting in an overall perioperative morbidity rate of 32%. In two patients major complications resulted in postoperative death (postoperative mortality rate 5.4%). Local success rate after RFA was 88% and the estimated 1-, 2- and 3-year overall survival rates were 84%, 70% and 43%, respectively.ConclusionThis strategy should only be performed following strict patient selection and within the context of prospective clinical trials.
Ejso | 2005
Maarten C. Jansen; R. van Hillegersberg; R.A.F.M. Chamuleau; O.M. van Delden; D. J. Gouma; T.M. van Gulik
Ejso | 2008
Maarten C. Jansen; S. van Wanrooy; R. van Hillegersberg; Arjen M. Rijken; F. van Coevorden; Warner Prevoo; T.M. van Gulik
Transactions of The Royal Society of Tropical Medicine and Hygiene | 2009
Natalie D. Snoeren; Maarten C. Jansen; Kate ten F. J. W; Gulik van T. M
Statistics in Medicine | 2005
Maarten C. Jansen; Duijnhoven van F. H; Richard van Hillegersberg; Arjen M. Rijken; Frits van Coevorden; Joost Rm van der Sijp; Warner Prevoo; Gulik van T. M